Cargando…
A narrative review of peripheral blood parameters for urothelial carcinoma treated with systemic antitumor drugs
BACKGROUND AND OBJECTIVE: The prognosis of advanced urothelial carcinoma (aUC) is poor. To date, the gold standard of treatment for patients with aUC has been cisplatin-based chemotherapy. More recently, immune checkpoint inhibitors (ICIs) have been widely used for such patients, which has led to an...
Autores principales: | Nagai, Takashi, Naiki, Taku, Sugiyama, Yosuke, Etani, Toshiki, Aoki, Maria, Gonda, Masakazu, Morikawa, Toshiharu, Iida, Keitaro, Tomiyama, Nami, Ando, Ryosuke, Kawai, Noriyasu, Yasui, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251088/ https://www.ncbi.nlm.nih.gov/pubmed/37305626 http://dx.doi.org/10.21037/tau-22-805 |
Ejemplares similares
-
A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy
por: Tomiyama, Nami, et al.
Publicado: (2022) -
Metastatic Urothelial Carcinoma with Glandular Differentiation That Confirmed the Response by Autopsy Specimen to Second-Line mFOLFOX6 (Fluorouracil, Oxaliplatin, and Leucovorin) plus Bevacizumab Chemotherapy
por: Naiki, Taku, et al.
Publicado: (2017) -
A Case of Metastatic Urothelial Carcinoma Treated with Pemetrexed as Third-Line Chemotherapy with Discussion and Literature Review
por: Iida, Keitaro, et al.
Publicado: (2015) -
A pilot study of gemcitabine and paclitaxel as third-line chemotherapy in
metastatic urothelial carcinoma
por: Naiki, Taku, et al.
Publicado: (2017) -
Gemcitabine and docetaxel as second-line chemotherapy in elderly patients with metastatic urothelial carcinoma: a retrospective analysis
por: Naiki, Taku, et al.
Publicado: (2018)